- E-postsynnove.yndestad@uib.no
- Telefon+47 55 97 64 44
- BesøksadresseHaukeland universitetssykehus, Laboratoriebygget5009 Bergen
- PostadressePostboks 78045020 Bergen
Vitenskapelig artikkel
- (2020). Olaparib monotherapy as primary treatment in unselected triple negative breast cancer. Annals of Oncology. 1-10.
- (2018). Divergent activity of the pseudogene PTENP1 in ER-positive and negative breast cancer. Molecular Cancer Research. 78-89.
- (2017). High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function. Breast Cancer Research and Treatment. 177-190.
- (2017). Activation of Akt characterizes estrogen receptor positive human breast cancers which respond to anthracyclines. OncoTarget. 41227-41241.
- (2016). Impaired lymphatic function accelerates cancer growth. OncoTarget. 45789-45802.
- (2015). Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo. Molecular Oncology. 1553-1564.
Vitenskapelig foredrag
- (2002). Microbial community analysis of a hydrocarbon-contaminated arctic soil from Svalbard.
Doktorgradsavhandling
- (2018). The role of PTEN, PI3K-Akt-mTOR signaling and pseudogene PTENP1 in breast cancer.
Poster
- (2019). Neoadjuvant olaparib monotherapy in primary triple negative breast cancer.
- (2002). Oil pollution in the Arctic and its effect on microbial diversity and ecology.
- (2002). Microbial community analysis of a hydrocarbon-contaminated arctic soil from Svalbard.